Goldman Sachs
AGL icon

Goldman Sachs’s Agilon Health AGL Stock Holding History

Goldman Sachs’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.6M Sell
686,792
-375,444
-35% -$24.6M 0.01% 1468
2026
Q1 		$8.4M Buy
1,062,236
+260,027
+32% +$4.2M ﹤0.01% 3206
2025
Q4 		$13.8M Buy
802,209
+531,358
+196% +$10.3M ﹤0.01% 2747
2025
Q3 		$6.97M Buy
270,851
+45,276
+20% +$1.71M ﹤0.01% 3326
2025
Q2 		$13M Buy
225,575
+23,162
+11% +$1.86M ﹤0.01% 2526
2025
Q1 		$21.9M Buy
202,413
+13,826
+7% +$1.2M ﹤0.01% 1954
2024
Q4 		$8.96M Sell
188,587
-40,642
-18% -$2.46M ﹤0.01% 2910
2024
Q3 		$22.5M Buy
229,229
+176,023
+331% +$22.7M ﹤0.01% 1953
2024
Q2 		$8.7M Buy
53,206
+28,356
+114% +$4.04M ﹤0.01% 2640
2024
Q1 		$3.79M Buy
24,850
+7,241
+41% +$1.2M ﹤0.01% 3350
2023
Q4 		$5.52M Buy
17,609
+8,445
+92% +$3.06M ﹤0.01% 3069
2023
Q3 		$4.07M Sell
9,164
-3,549
-28% -$1.6M ﹤0.01% 3171
2023
Q2 		$5.51M Buy
12,713
+1,999
+19% +$1.12M ﹤0.01% 3017
2023
Q1 		$6.36M Sell
10,714
-14,325
-57% -$8.02M ﹤0.01% 2824
2022
Q4 		$10.1M Sell
25,039
-3,009
-11% -$1.41M ﹤0.01% 2579
2022
Q3 		$16.4M Buy
28,048
+3,656
+15% +$2.19M ﹤0.01% 2051
2022
Q2 		$13.3M Buy
24,392
+3,353
+16% +$1.7M ﹤0.01% 2237
2022
Q1 		$13.3M Sell
21,039
-3,245
-13% -$1.67M ﹤0.01% 2400
2021
Q4 		$16.4M Buy
24,284
+23,419
+2,707% +$14.3M ﹤0.01% 2308
2021
Q3 		$567K Buy
+865
New +$739K ﹤0.01% 5122

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Goldman Sachs's AGL Position: Q2 2026 in Review

Goldman Sachs reduced its Agilon Health (AGL) stake by 35% in Q2 2026, selling an estimated $24.6M and leaving 686,792 shares worth $73.6M. The position accounts for 0.01% of the portfolio, ranked #1468.

Goldman Sachs first reported a position in AGL in Q3 2021 and has held it in 20 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Goldman Sachs held 686,792 shares of Agilon Health worth $73.6M as of Q2 2026.
  • Goldman Sachs sold 375,444 Agilon Health shares in Q2 2026, an estimated $24.6M.
  • Agilon Health made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1468 holding.
  • Goldman Sachs first reported a position in Agilon Health in Q3 2021 and has held it in 20 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.